And we also did something really very-very cutting-edge. And that is, we did telehealth services 20 years ago. We did #telehealth service on the phone – not video – on the phone, talking to…
Continue Reading
What You Should Know:
– Cleerly, a pioneer in advanced cardiovascular imaging, has announced the successful closure of its Series C extension funding round, raising a total of $106M led by Insight Partners, with participation…
Continue Reading
Welcome to the November edition of Digital Health Digest!In this episode, we cover key updates in digital health, including innovative AI patents, advancements in remote patient monitoring, and the latest global strategies for transforming…
Continue Reading
Wearables-maker Movano Health announced it received FDA 510(k) clearance for its health-monitoring wearable, EvieMED Ring. EvieMED Ring is a smart ring that combines medical and wellness metrics, including blood oxygen levels, heart rate and metrics…
Continue Reading
Welcome to an enlightening interview with Gerald Finken, the founder and CEO of RxE2.Join us as we delve into Gerald's journey as a digital health entrepreneur and explore how RxE2 is transforming the clinical…
Continue Reading
Researchers from the National Institutes of Health are using large language models to develop an artificial intelligence framework to streamline the clinical trial matching process and more quickly link potential volunteers to relevant trials…
Continue Reading
Sujay Jadhav, CEO of Verana Health
While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life…
Continue Reading
Join ASTP for an overview of USCDI+ respiratory illness, providing you with the latest insights and an opportunity to share your feedback. During the session, we will give an overview of USCDI+ Respiratory Illness…
Continue Reading
Synapticure, a telemedicine company focused on people and caregivers living with neurodegenerative diseases, announced it has raised $25 million in a Series A funding round led by B Capital. New investors CVS Health Ventures, RA…
Continue Reading
The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which…
Continue Reading
